Contract Manufacturing

© GettyImages/Cecilie_Arcurs

Novartis inks contract manufacturing deal with Carisma

By Jane Byrne

Novartis continues down the third-party manufacturing route, as it secures an agreement with Carisma Therapeutics, a firm developing a cell therapy platform focused on engineered macrophage-based therapeutics.

(RUNSTUDIO/iStock via Getty Images Plus)

CPHI NORTH AMERICA 2021

M&A activity vigorous in CDMO arena: CPhI

By Jenni Spinner

An expert speaking during the industry event offers insight and perspective on the flurry of CDMO deal-making in recent months, and what might lie ahead.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers